PL352591A1 - Permanent pharmaceutical oral dosed form and method of manufacture of permanent pharmaceutical oral dosed form - Google Patents

Permanent pharmaceutical oral dosed form and method of manufacture of permanent pharmaceutical oral dosed form

Info

Publication number
PL352591A1
PL352591A1 PL02352591A PL35259102A PL352591A1 PL 352591 A1 PL352591 A1 PL 352591A1 PL 02352591 A PL02352591 A PL 02352591A PL 35259102 A PL35259102 A PL 35259102A PL 352591 A1 PL352591 A1 PL 352591A1
Authority
PL
Poland
Prior art keywords
pharmaceutical oral
dosed form
permanent
oral dosed
manufacture
Prior art date
Application number
PL02352591A
Other languages
Polish (pl)
Inventor
Marian Mikołaj Zgoda
Marian Iwańczyk
Wojciech Jerzy Kierociński
Original Assignee
Medana Pharma Terpol Group S.A.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Medana Pharma Terpol Group S.A. filed Critical Medana Pharma Terpol Group S.A.
Priority to PL02352591A priority Critical patent/PL352591A1/en
Priority to PCT/PL2003/000018 priority patent/WO2003074064A1/en
Publication of PL352591A1 publication Critical patent/PL352591A1/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2059—Starch, including chemically or physically modified derivatives; Amylose; Amylopectin; Dextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/2027—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Biotechnology (AREA)
  • Botany (AREA)
  • Medical Informatics (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Plant Substances (AREA)
PL02352591A 2002-03-04 2002-03-04 Permanent pharmaceutical oral dosed form and method of manufacture of permanent pharmaceutical oral dosed form PL352591A1 (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
PL02352591A PL352591A1 (en) 2002-03-04 2002-03-04 Permanent pharmaceutical oral dosed form and method of manufacture of permanent pharmaceutical oral dosed form
PCT/PL2003/000018 WO2003074064A1 (en) 2002-03-04 2003-03-04 Solid composition containing isoflavonoids for oral administration and method of obtaining same

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PL02352591A PL352591A1 (en) 2002-03-04 2002-03-04 Permanent pharmaceutical oral dosed form and method of manufacture of permanent pharmaceutical oral dosed form

Publications (1)

Publication Number Publication Date
PL352591A1 true PL352591A1 (en) 2003-09-08

Family

ID=27786559

Family Applications (1)

Application Number Title Priority Date Filing Date
PL02352591A PL352591A1 (en) 2002-03-04 2002-03-04 Permanent pharmaceutical oral dosed form and method of manufacture of permanent pharmaceutical oral dosed form

Country Status (2)

Country Link
PL (1) PL352591A1 (en)
WO (1) WO2003074064A1 (en)

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE275959T1 (en) * 1992-05-19 2004-10-15 Graham Edmund Kelly USE OF ISOFLAVONE PHYTO-ESTROGEN EXTRACTS OF SOY OR CLOVER
US6146668A (en) * 1997-04-28 2000-11-14 Novogen, Inc. Preparation of isoflavones from legumes
US6083526A (en) * 1997-05-22 2000-07-04 Gorbach; Sherwood L. Use of isoflavonoids in the treatment or prevention of postpartum depression

Also Published As

Publication number Publication date
WO2003074064A1 (en) 2003-09-12

Similar Documents

Publication Publication Date Title
EP1615623A4 (en) Abuse-resistant oral dosage forms and method of use thereof
EP1365747A4 (en) Oral peptide pharmaceutical dosage form and method of production
EP1383518A4 (en) Oral delivery of macromolecules
MXPA03007613A (en) Compositions and methods of manufacture for oral dissolvable dosage forms.
EP1443905A4 (en) Compositions for oral gene therapy and methods of using same
PL357856A1 (en) Pharmaceutical granules containing tamsulozine and method of their manufacture
EP1701691A4 (en) Methods and compositions for oral hygiene
EP1478345A4 (en) Novel pharmaceutical dosage forms and method for producing same
PL364621A1 (en) Nicotine-containing oral dosage form
AU2003267644A8 (en) Dental compositions and methods
HK1091727A1 (en) Nasal pharmaceutical formulations and methods of using the same
AU2003298583A8 (en) Chewing gum formulation and method of making the same
AU2003269444A8 (en) An improved pacifier and method of use thereof
IL166337A0 (en) Oral administration of calctionin
HK1066459A1 (en) Pharmaceutical dosage form and method of making
AU2003291700A8 (en) Oral hygiene system and method of treatment
PL372773A1 (en) Oral administration of epothilones
AU2003267084A8 (en) Mass flow hopper and method of manufacture
PL378269A1 (en) Oral care compositions and methods
IL175746A0 (en) Oral formulations of desoxypeganine and uses thereof
AU2003294684A8 (en) Ketoprofen compositions and methods of making them
AU2003256157A1 (en) Oral dosage forms of water insoluble drugs and methods of making the same
EP1581258A4 (en) Pharmaceutical formulation and a method of making same
IL162716A0 (en) Oral pharmaceutical compositions for soft capsulescontaining vinorelbine and method of treatment
PL352591A1 (en) Permanent pharmaceutical oral dosed form and method of manufacture of permanent pharmaceutical oral dosed form

Legal Events

Date Code Title Description
DISC Decisions on discontinuance of the proceedings (taken after the publication of the particulars of the applications)